Strong Growth in Life Sciences
R2 posted worldwide top line sales of $5.7 million, a record high. Year-to-date sales grew 217% compared to the same period last year, and system unit sales worldwide saw a massive increase of 416% from third quarter '23 to third quarter '24.
Improved Margins in DBM Global
DBM Global achieved a gross margin improvement year-over-year of approximately 360 basis points to 18.8% and adjusted EBITDA year-over-year by approximately 70 basis points to 9%.
Spectrum Segment Profitability
Spectrum achieved adjusted EBITDA of $1.7 million in the third quarter, a $2 million improvement year-over-year. Year-to-date, Spectrum has delivered $4.8 million in adjusted EBITDA, a significant increase compared to $900,000 through the first 9 months of 2023.
Expansion and Brand Awareness for R2
R2 expanded its international footprint and saw significant growth in brand awareness, evidenced by a 4,086% increase in social mentions and a 498% increase in web users.